Healthcare and Life Science
Johnson Matthey signs agreement to sell its Medical Device Components business for US$700m
Johnson Matthey Plc (JM) announces that it has signed a definitive agreement to sell 100% of its Medical Device Components business (MDC) to Montagu Private Equity (Montagu) for cash consideration of US$700 million (£550 million) on a cash free debt free basis. ...
ArgusEye introduces AugaOne to accelerate downstream bioprocess development
AugaOne sensor system provides specific, real-time, and automated data to reduce mAb process development time New sensor will be exhibited at the Bioprocessing Summit, 18-21 March 2024, booth 66 Linköping, Sweden, 21 March 2024: ArgusEye, a provider of innovative sensor solutions ...
SolasCure Awarded £405K Innovate UK Biomedical Catalyst Grant to Advance Chronic Wound Care
Funding will be used to further optimize Aurase Wound Gel for future clinical trials SolasCure aims to deliver the first efficacious, cost-effective, and pain-free solution for millions of patients suffering from chronic wounds Cambridge, UK 20 March 2024: SOLASCURE Ltd (SolasCure)...
Semarion introduces SemaCyte Multiplexing Platform to enhance cell assay data quality and speed during drug discovery
Expansion to SemaCyte Microcarrier platform enables optical barcoding and pooling of adherent cells to augment drug discovery high-content imaging and other screening processes Access available through Semarion’s Early Adopter Program Cambridge, UK : Semarion Ltd, a University of C...
SPT Labtech to co-market streamlined NGS library preparation workflows for both PCR and PCR-free applications with Roche
Cambridge, UK, 19 March 2024 –
Nuclera Joins Tech Nation’s Future Fifty Program
Nuclera recognized as one of UK’s most exciting growth stage companies Official launch of 2024 cohort taken place at 10 Downing Street Cambridge, UK, 19 March 2024: Nuclera, the biotechnology company enabling rapid protein expression and purification screening through its eProtein...
Guardtech Group take total cleanroom package to next level with new Isopod Rapid Cleanrooms website
Suffolk-based cleanroom design & build experts launch their fifth new subsite in the space of a year ...
AstraZeneca to acquire Amolyt Pharma, expanding late-stage rare disease pipeline
Amolyt development portfolio includes Phase III asset with potential to address significant unmet need in patients with chronic hypoparathyroidism Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition, building on company’s success ...
Arrayjet’s ArrayPlex platform selected by Immunome for use in its discovery of targeted cancer therapies
Arrayjet’s patented spot-on-spot microarray screening technology is available for customers to adopt in-house and via Arrayjet’s CRO/CMO services Immunome signs deal to use Arrayjet platform in its in-house screening operations Edinburgh, Scotland, 18 March 2024: Arrayjet, a leadin...
EFEC in Lingang, Shanghai helping to develop next stages of the Lingang Cambridge Network
In 2019, EFEC worked with Cambridge Network and the Shanghai Lingang Construction and Investment Company to set up the Lingang Cambridge Network, in Lingang, Shanghai. The pandemic then intervened, but EFEC is now back working with the LCN to develop the network and the basis for enhan...